Search research articles
Contact Us
Filters
Showing results (11-20 of 121) with videos related to
Page
of 13
Sort By:
Current Medicinal Chemistry
|
September 1, 2012
Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy
M Drent, P Wijnen, A Bast
The European Respiratory Journal
|
November 6, 2007
Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?
J A Bakker, J Bierau, M Drent
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
February 6, 2016
Infliximab or biosimilars in sarcoidosis; to switch or not to switch?
M Veltkamp, M Drent, R P Baughman
The European Respiratory Journal
|
October 9, 2010
A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?
J A Bakker, J Bierau, M Drent
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
November 29, 2013
Om Prakash Sharma, MD, FRCP, FCCP. 4 July 1936-19 August 2012. Internationally acclaimed specialist in sarcoidosis
R P Baughman, M Drent, U Costabel
Respiratory Medicine
|
April 28, 2000
Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used?
J De Vries, A Seebregts, M Drent
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
November 5, 1997
A manifestation of sarcoidosis in a woman with Marfan's syndrome
N A Cobben, R J Lamers, M Drent
The European Respiratory Journal
|
August 8, 2001
Quality of life of idiopathic pulmonary fibrosis patients
J De Vries, B L Kessels, M Drent
Nederlands Tijdschrift Voor Geneeskunde
|
September 13, 1986
[Stress and immunity: the importance of multidisciplinary research]
M Drent, H G Kho, J van Egmond
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
April 23, 2009
Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them
R P Baughman, E E Lower, M Drent
Page
of 13
Search research articles
Search
Showing results (11-20 of 121) with videos related to
Sort By:
Page
of 13
Current Medicinal Chemistry
|
September 1, 2012
Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy
M Drent, P Wijnen, A Bast
The European Respiratory Journal
|
November 6, 2007
Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?
J A Bakker, J Bierau, M Drent
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
February 6, 2016
Infliximab or biosimilars in sarcoidosis; to switch or not to switch?
M Veltkamp, M Drent, R P Baughman
The European Respiratory Journal
|
October 9, 2010
A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?
J A Bakker, J Bierau, M Drent
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
November 29, 2013
Om Prakash Sharma, MD, FRCP, FCCP. 4 July 1936-19 August 2012. Internationally acclaimed specialist in sarcoidosis
R P Baughman, M Drent, U Costabel
Respiratory Medicine
|
April 28, 2000
Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used?
J De Vries, A Seebregts, M Drent
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
November 5, 1997
A manifestation of sarcoidosis in a woman with Marfan's syndrome
N A Cobben, R J Lamers, M Drent
The European Respiratory Journal
|
August 8, 2001
Quality of life of idiopathic pulmonary fibrosis patients
J De Vries, B L Kessels, M Drent
Nederlands Tijdschrift Voor Geneeskunde
|
September 13, 1986
[Stress and immunity: the importance of multidisciplinary research]
M Drent, H G Kho, J van Egmond
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
April 23, 2009
Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them
R P Baughman, E E Lower, M Drent
Page
of 13